Stawicki S Peter, Brooks Adam, Bilski Tracy, Scaff David, Gupta Rajan, Schwab C William, Gracias Vicente H
Department of Surgery, Division of Traumatology and Surgical Critical Care, University of Pennsylvania School of Medicine, 3340 Market Street, Philadelphia, PA 19104, USA.
Injury. 2008 Jan;39(1):93-101. doi: 10.1016/j.injury.2007.06.011. Epub 2007 Sep 20.
A damage control (DC) approach was developed to improve survival in severely injured trauma patients. The role of DC in acute surgery (AS) patients who are critically ill, as a result of sepsis or overwhelming haemorrhage continues to evolve. The goal of this study was to assess morbidity and mortality of AS patients who underwent DC, and to compare observed and predicted morbidity and mortality as calculated from APACHE II and physiological and operative severity score for the enumeration of mortality and morbidity (POSSUM) scores.
Consecutive acute surgery patients who underwent DC from 2002 to 2004 were included. Retrospectively collected data included patient demographics, physiological parameters, surgical indications and procedures, mortality, morbidity, as well as volumes of crystalloid and colloid (plasma and red blood cell) resuscitation. Observed mortality and complications were compared to those calculated from APACHE II and POSSUM scores. Data were analysed using the Mann-Whitney test for median values, chi-square and Fisher's exact tests for proportions.
Sixteen patients (mean age 53 years, seven men, nine women) underwent DC. The most common indications for DC included abdominal sepsis (6/15), intraoperative bleeding (5/15), and bowel ischaemia (3/15). The mean intraoperative blood loss during the index procedure was 2060mL. There were 2.4 average procedures per patient. At the end of DC II (36.5h), mean infusion of crystalloid was 17L, packed red blood cells was 3.6L, and plasma was 3L. Eight of 16 patients required vasopressor administration during resuscitation. At 28 days, there were five unexpected survivors as predicted by POSSUM and three by APACHE II (observed mortality seven, predicted mortality by the two methods: 12 (P=0.074), and 10 (P=0.24), respectively). Five patients died prior to definitive abdominal closure. Split thickness skin grafting (4/16) and primary fascial closure (4/16) constituted the most common methods of abdominal closure. Surgical morbidity predicted by POSSUM (98%) and actual morbidity (100%) were similar.
Although the morbidity and mortality of AS patients undergoing DC is high, the application of DC principles in this group may reduce mortality compared to that predicted by POSSUM or APACHE II. In order to adequately demonstrate this contention, large, multi-institutional studies of DC in AS patients need to be performed. The POSSUM score appears to accurately estimate the high morbidity in general surgery DC patients, and supports the importance of team management of these complex patients by acute care surgery specialists.
为提高严重创伤患者的生存率,人们开发了损伤控制(DC)方法。DC在因脓毒症或严重出血而危重症的急性手术(AS)患者中的作用仍在不断演变。本研究的目的是评估接受DC的AS患者的发病率和死亡率,并比较观察到的发病率和死亡率与根据急性生理与慢性健康状况评分系统(APACHE II)以及用于计算死亡率和发病率的生理和手术严重程度评分(POSSUM)所预测的发病率和死亡率。
纳入2002年至2004年连续接受DC的急性手术患者。回顾性收集的数据包括患者人口统计学、生理参数、手术指征和手术、死亡率、发病率以及晶体液和胶体液(血浆和红细胞)复苏量。将观察到的死亡率和并发症与根据APACHE II和POSSUM评分计算出的结果进行比较。使用Mann-Whitney检验分析中位数,使用卡方检验和Fisher精确检验分析比例。
16例患者(平均年龄53岁,7例男性,9例女性)接受了DC。DC最常见的指征包括腹部脓毒症(6/15)、术中出血(5/15)和肠缺血(3/15)。初次手术期间的平均术中失血量为2060mL。每位患者平均进行2.4次手术。在DC II结束时(36.5小时),晶体液的平均输注量为17L,浓缩红细胞为3.6L,血浆为3L。16例患者中有8例在复苏期间需要使用血管活性药物。在28天时,有五例意外存活者,POSSUM预测有三例,APACHE II预测有三例(观察到的死亡率为7例,两种方法预测的死亡率分别为12例(P=0.074)和10例(P=0.24))。五例患者在确定性腹部关闭之前死亡。分层皮片移植(4/16)和一期筋膜关闭(4/16)是最常见的腹部关闭方法。POSSUM预测的手术发病率(98%)与实际发病率(100%)相似。
尽管接受DC的AS患者的发病率和死亡率很高,但与POSSUM或APACHE II所预测的相比,在该组患者中应用DC原则可能会降低死亡率。为了充分证明这一论点,需要对AS患者进行DC的大型多机构研究。POSSUM评分似乎能准确估计普通外科DC患者的高发病率,并支持急性护理外科专家对这些复杂患者进行团队管理的重要性。